Press Releases

ClearNote Health Receives First In Vitro Diagnostic Approval for its Avantect® Pancreatic Cancer Test

ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced that it has received UK Conformity Assessed (UKCA) marking for its Avantect® Pancreatic Cancer Test. The UKCA mark, established as part of the United Kingdom’s independent product safety regulatory framework following its departure from the European Union, signifies compliance with UK medical device regulations and paves the way for commercial availability in the UK market.

ProPharma Appoints Marshall Florence, Ex-FDA Labeling Expert, as Vice President of Labeling to Advance Strategic Labeling & Promotional Review

New hire elevates strategic labeling solutions to support faster approval and smarter commercialization

Upperton Pharma Solutions Wins Business Expansion Award at the 2025 Pharmaceutical Technology Excellence Awards.

Nottingham, UK – [07.07.2025] – Upperton Pharma Solutions, a leading Nottingham-based pharmaceutical contract development and manufacturing organisation (CDMO), is delighted to announce its recognition as the winner of the Business Expansion award in the Integrated Manufacturing category at the 2025 Pharmaceutical Technology Excellence Awards.

CD Bioparticles Launches Advanced Bio-Targeted Small Molecules Conjugated Magnetic Nanoparticles for Targeted Cancer Therapy

CD Bioparticles announces its custom synthesis services of Bio-Targeted Small Molecules Conjugated Magnetic Nanoparticles (MNPs).

Axplora announces further €35M expansion at Farmabios to double footprint and fuel long-term growth

Creative Diagnostics Announces Advanced Microbial Genome Editing Services to Accelerate Bio-research

Creative Diagnostics launches Microbial Genome Editing services to support bioresearch.

Headlands Research Enters the Caribbean with Acquisition of CMRCenter

The deal pairs San Juan, Puerto Rico site’s deep community ties, top-tier enrollment, and 90% retention with Headlands’ network-wide infrastructure and resources to accelerate clinical research

PHARMASEAL and Viedoc Announce a Technical Integration Partnership

PHARMASEAL, provider of the Engility® Trial Management Platform consisting of a Clinical Trial Management System (CTMS) CTMS and Electronic Trial Master File (eTMF), has announced a Technology Integration Partnership with Viedoc, a global leader in Electronic Data Capture (EDC) and eClinical technologies. This collaboration integrates PHARMASEAL’s advanced CTMS platform with Viedoc’s cutting-edge EDC capabilities, including its flagship product Viedoc Clinic, to deliver a more integrated solution for life science companies managing clinical trials worldwide.

Gene by Gene Supports Landmark Pharmacogenomics Trial to Personalize Prescribing in NHS Scotland

Gene by Gene Supports Landmark Pharmacogenomics Trial to Personalize Prescribing in NHS Scotland

Takara Bio Europe signs distribution agreement with MACHEREY-NAGEL to expand access to high-quality bioanalysis products

Takara Bio Europe is pleased to announce it has entered into a distribution agreement with MACHEREY-NAGEL to expand access to high-quality bioanalysis products.

Alithea Genomics Announces the Launch of MERCURIUS™ FLASH-seq: A Plate-Based, Full-Length Single Cell RNA-seq Kit Delivering Exceptional Sensitivity and Simplicity

Alithea Genomics has announced the commercial launch of MERCURIUS™ FLASH-seq, a next-generation library preparation kit for full-length single-cell RNA sequencing.

Phastar appoints Industry Veteran Billy Amzal as Head of Strategic Consulting

Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), today announced the appointment of Billy Amzal as Head of Strategic Consulting.

New Collaboration Initiative: Alfa Chemistry Announces Inclusion as a Listed Supplier across CHEMnetBASE Dictionaries

To make it easier for researchers to find and access the specialized chemicals they need, Alfa Chemistry has announced that it has been added as a supplier to the CHEMnetBASE dictionaries, the world’s premier collection of interactive chemistry databases from CRC Press, Taylor & Francis Group. This means that Alfa Chemistry’s vast catalog of specialized chemicals will be easily discoverable within the premier digital chemistry resource used by researchers and scientists around the world.

Association for Molecular Pathology Publishes Best Practice Recommendations for Clinical HRD Testing

AMP recently published a new report with 12 best practice recommendations focused on the design and validation of clinical HRD assays. To develop these recommendations, AMP assembled an expert panel that included organizational representation from ACCC, ASCO, and the CAP.

Alithea Genomics Launches MERCURIUS™ Total DRUG-seq: A Next-Generation Full-Length Transcriptome Profiling Platform for High-Throughput Compound Screening and Target Validation

Alithea Genomics has announced the launch of MERCURIUS™ Total DRUG-seq to push the boundaries of high-throughput drug screens, toxicology screens and target validation.

Lindus Health Named Fierce CRO Award Winner in the Outstanding Patient Recruitment and Retention Category

Lindus Health Named Fierce CRO Award Winner in the Outstanding Patient Recruitment and Retention Category

Symbiosis Expands Global Reach with Key Appointment of Angelika Rublack as Senior Business Development Manager

One2Treat, the leading company incorporating the patient voice into clinical development, launches One2Treat Voice app

One2Treat SA, a fast-growing tech company incorporating the patient voice in all strategic decisions about treatment assessments in Pharma R&D, today announced the launch of the One2Treat Voice app, a new module of their software platform.

START Launches Hope Hub to Connect Patients, Physicians, and Advocacy Groups to Community-Based Cancer Trials

The new platform is designed to break down barriers to early-phase trial access, bringing "Hope Through Access" to communities and patients who need it most.

Advarra establishes AI council in partnership with life sciences leaders to drive collaboration and advance innovation in clinical trials

Sanofi, Recursion, and Velocity Clinical Research executives join AI council as founding members to guide responsible AI use in clinical research and drive tangible improvements in study design and operational outcomes